Roongroj Bhidayasiri

Thai Red Cross Society — Thailand

Medicine · Health Sciences

44h-index7.4kcitations482works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurological disorders and treatments(232), Parkinson's Disease Mechanisms and Treatments(220), Botulinum Toxin and Related Neurological Disorders(104), Genetic Neurodegenerative Diseases(93), Neurological and metabolic disorders(45)

Publications482 total

Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases
npj Parkinson s Disease·2025Open Access
From clutter to confidence: home environmental triggers and adaptive solutions for freezing of gait in Parkinson’s disease
Journal of Neural Transmission·2025
Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report
Movement Disorders Clinical Practice·2025· 1 citedOpen Access
Parkinson’s disease severity clustering based on gait activity from mobile device
Scientific Reports·2025Open Access
Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review
Movement Disorders·2025Open Access
Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs
Movement Disorders Clinical Practice·2025
Enriching Global Perspectives Through a Regional Lens: Recognition, Assessment, and Management of Tardive Dyskinesia in Southeast Asia
Journal of Movement Disorders·2025Open Access
Neuroscience in Asia-Pacific : Horizons and Innovations
IBRO Neuroscience Reports·2025Open Access
Corneal Hypersensitivity Precedes Degeneration in High-Risk Parkinson’s Disease
2025Open Access
Reply to the commentary on Defining ‘OFF’ time in device-aided therapy criteria for Parkinson’s disease: Gaps and opportunities
Parkinsonism & Related Disorders·2025
The resurrection of apomorphine: A dopamine analogue comparable in potency to L-DOPA
Parkinsonism & Related Disorders·2025· 1 cited
Defining ‘OFF’ time in device-aided therapy criteria for Parkinson’s disease: gaps and opportunities
Parkinsonism & Related Disorders·2025· 3 cited
Optimizing Device-Aided Therapies in Advanced Parkinson’s Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios
Journal of Movement Disorders·2025· 1 citedOpen Access
Empowering patients: A multimodal digital health technology survey of patients with neurogenerative disorders and immune-mediated inflammatory diseases
Digital Health·2025Open Access
Vital nutrition: enhancing health in advanced Parkinson’s disease with device-aided therapies
Journal of Neural Transmission·2025· 2 citedOpen Access
A young man with progressive dysarthria, generalized slowness and memory loss
Parkinsonism & Related Disorders·2025
Effect of Virtual Reality Meditation on Gait Parameters in Parkinson’s Disease Patients with Freezing of Gait: A Pilot Study
Parkinsonism & Related Disorders·2025
Optimized use of safinamide as an add-on therapy in Asian patients with Parkinson’s disease: a narrative review and expert opinion
Therapeutic Advances in Neurological Disorders·2025· 1 citedOpen Access
Comparative efficacy of Mucuna pruriens and conventional levodopa in Parkinson’s disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from Asia
Journal of Neural Transmission·2025· 4 cited
Correction: The centenarian blueprint: lessons in defying Parkinson’s disease
Journal of Neural Transmission·2025Open Access
page 1 of 25Next →

Frequent Co-authors

К. Ray Chaudhuri(9), Raymond L. Rosales(6), Cristian Falup‐Pecurariu(5), Onanong Jitkritsadakul(5), Daniel Truong(5), Angelo Antonini(4), Pablo Martínez‐Martín(4), Per Odin(4), Mayela Rodríguez‐Violante(4), Beomseok Jeon(4), Valentina Leta(4), Jirada Sringean(4), Chusak Thanawattano(4), Alfonso Fasano(3), Fabrizio Stocchi(3), Nobutaka Hattori(3), Vinod Metta(3), Victor S.C. Fung(3), Claudia Trenkwalder(3), Shen‐Yang Lim(3)